Life-Threatenting Ceftriaxone-Induced Immune Hemolytic Anemia in a Child with Crohn's Disease

Clinical Pediatrics

Volumn 43, Issue 2, 2004, Pages 175-178

  Mattis, Lynn E ^a   Saavedra, Jose M ^b   Shan, Hua ^b   Shirey, R Sue ^a   Powell, Eric ^b   Oliva Hemker, Maria M ^a,b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; CEFTRIAXONE; DIPHENHYDRAMINE; GENTAMICIN; IMMUNOGLOBULIN M; LACTATE DEHYDROGENASE; LORAZEPAM; MERCAPTOPURINE; METHYLPREDNISOLONE SODIUM SUCCINATE; PIPERACILLIN PLUS TAZOBACTAM; PREDNISONE;

ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BACKACHE; CASE REPORT; CATHETER INFECTION; CLINICAL EXAMINATION; CROHN DISEASE; ENTEROBACTER CLOACAE; HUMAN; MALE; SCHOOL CHILD; SEPSIS; TACHYCARDIA; TONIC CLONIC SEIZURE; VOMITING;

ANEMIA, HEMOLYTIC; ANTI-BACTERIAL AGENTS; CATHETERIZATION, CENTRAL VENOUS; CEFTRIAXONE; CHILD; CROHN DISEASE; HUMANS; MALE;

EID: 1542375861     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992280404300207     Document Type: Article

References (18)

1. Arndt P, Leger R, Garratty G. Serology of antibodies to second- and third-generation cephalosporins associated with immune hemolytic anemia and/or positive direct antiglobulin tests. Transfusion. 1999;39:1239-1246.
2. Lascari AD, Amyot K. Fatal hemolysis caused by ceftriaxone. J Pediatr. 1995;126:816-817.
3. Bernini JC, Mustafa MM, Sutor LJ, Buchanan GR. Fatal hemolysis induced by ceftriaxone in a child with sickle cell anemia. J Pediatr 1995;126:814-816.
4. Borgna-Pignatti C, Bezzi TM, Reverberi R. Fatal ceftriaxone-induced hemolysis in a child with acquired immunodeficiency syndrome. Pediatr Infect Dis J. 1995;14:1116-1117.
5. Scimeca PG, Weinblatt ME, Boxer R. Hemolysis after treatment with ceftriaxone. J Pediatr. 1996;128:163.
6. Moallem HJ, Garratty G, Wakeham M, et al. Ceftriaxone-related fatal hemolysis in an adolescent with perinatally acquired human immunodeficiency virus infection. J Pediatr. 1998;133:279-281.
7. Meyer O, Hackstein H, Hoppe B, et al. Fatal immune haemolysis due to a degradation product of ceftriaxone. Br J Haematol. 1999;105:1084-1085.
8. Viner Y, Hashkes P, Yakubova R, et al. Severe hemolysis induced by ceftriaxone in a child with sickle-cell anemia. Pediatr Infect Dis J. 2000;19:83-84.
9. Garratty G, Postoway N, Schwellenbach J, McMahill PC. A fatal case of ceftriaxone (Rocephin)-induced hemolytic anemia associated with intravascular immune hemolysis. Transfusion. 1991;31:176-179.
10. Longo F, Hastier P, Buckley M, et al. Acute hepatitis, autoimmune hemolytic anemia and erythroblastocytopenia induced by ceftriaxone. Am J Gastroenterol. 1998;93:836-837.
11. Maraspin V, Lotric-Furlan S, Strle F. Ceftriaxone-associated hemolysis. Wien Klin Wochenschr. 1999;111:368-370.
12. Seltsam A, Salama A. Ceftriaxone-induced immune haemolysis: two case reports and a concise review of the literature. Intensive Care Med. 2000; 26:1390-1394.
13. Falezza GC, Piccoli PL, Franchini M, et al. Ceftriaxone-induced hemolysis in an adult. Transfusion. 2000;40:1543-1544.
14. Oliva-Hemker M, Fiocchi C. Etiopathogenesis of inflammatory bowel disease: the importance of the pediatric perspective. Inflamm Bowel Dis. 2002;8:112-128.
15. Nielsen OH, Vainer B, Rask-Madsen J. Review article: the treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine. Aliment Pharmacol Ther 2001;15:1699-1708.
16. Goldfinger D. Acute hemolytic transfusion reactions-a fresh look at pathogenesis and considerations regarding therapy. Transfusion. 1977;17:85-98.
17. Brecher ME. Hemolytic transfusion reactions. In: Rossi EC, Simon TL, Moss GS, Gould SA, eds. Principles of Transfusion Medicine. Baltimore: Williams & Wilkins, 1996:747-763.
18. Shirey RS, Bartholomew J, Bell W, et al. Characterization of antibody and selection of alternative drug therapy in hydrochlorothiazide-induced immune hemolytic anemia. Transfusion. 1989;28:70-72.